Congenital Anomalies of the Liver and Biliary Tract

Overview

Uncommon biliary anomalies: AGENESIS, DUPLICATION, HETEROTOPIC TISSUE. More frequently diagnosed group = CONGENITAL CYSTIC LESIONS.

Congenital cystic lesions

Congenital intrahepatic biliary dilatation (CAROLI’S DISEASE)
Choledochal cysts
Polycystic liver disease
Congenital hepatic fibrosis

Occur in various COMBINATIONS, usually INHERITED. ALL carry MALIGNANT TRANSFORMATION risk.

Related (see Hepatic Tumours)

Congenital hepatic cysts: small(<1cm), biliary-epithelium-lined, single or as POLYCYSTIC LIVER DISEASE (often + polycystic kidney). Abundant connective tissue+numerous ducts variant = CONGENITAL HEPATIC FIBROSIS.

Clinical relevance

“Usually inherited + ALL carry malignant potential” = organising fact — these are NOT lifelong-benign curiosities despite congenital origin, warrant ongoing surveillance. Polycystic liver disease’s frequent polycystic KIDNEY association (cross-ref Polycystic Kidney Disease) = prompt to actively check the other organ when one is found. Congenital hepatic fibrosis’s defining feature(abundant connective tissue+numerous ducts within a cyst) = morphologic distinguisher from ordinary congenital cyst — spectrum, not sharply separate entities.

Overview

Several uncommon congenital anomalies of the biliary system have been described: agenesis, duplication, and heterotopic tissue. However, the more frequently diagnosed group is congenital cystic lesions of the bile ducts and liver.

Congenital Cystic Lesions

This group includes:

Congenital intrahepatic biliary dilatation (Caroli’s disease)
Choledochal cysts
Polycystic liver disease
Congenital hepatic fibrosis

These conditions occur in various combinations with one another and are usually inherited. All of them carry a risk of malignant transformation.

Related Entities Covered Elsewhere

Some of these overlap with hepatic cystic disease discussed under Hepatic Tumours: congenital hepatic cysts are usually small (<1 cm), biliary-epithelium-lined, and may occur singly or as polycystic liver disease — often associated with polycystic kidney disease. When such cysts show abundant connective tissue and numerous ducts, the designation congenital hepatic fibrosis applies.

Clinical Relevance

The shared “usually inherited, all carry malignant potential” framing is the single organising fact for this group — despite being congenital/developmental in origin, these lesions are not lifelong-benign curiosities and warrant ongoing surveillance rather than being dismissed once identified.
Polycystic liver disease’s frequent association with polycystic kidney disease (cross-reference Polycystic Kidney Disease) is worth remembering as a prompt to actively look for the other organ’s involvement whenever one is found, since the two conditions share overlapping genetic and developmental origins.
Congenital hepatic fibrosis’s defining feature — abundant connective tissue and numerous ducts within what would otherwise be a simple congenital cyst — is the morphologic distinguisher from an ordinary congenital hepatic cyst, worth anchoring precisely since the two lie on a spectrum rather than being sharply separate entities.